Treatment of Erysipeloid in Patients with No Intolerance to Penicillin

This protocol applies to patients diagnosed with erysipeloid who have no known intolerance to penicillin. The absence of penicillin intolerance is the key clinical factor that determines which first-line treatment pathway is appropriate.

For patients without penicillin intolerance, first-line management of erysipeloid involves an oral penicillin-class antibiotic. The structured protocol specifies the agent options, the dosing schedule, and the recommended course duration.

Full details — including agent selection, frequency, and duration — are in the protocol below.